This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Laparoscopic herniorrhaphy

Authoring team

Laparoscopic herniorrhaphy is performed transabdominally. It has less to commend it - in contrast to other laparoscopic procedures - relative to more traditional procedures: open herniorrhapy is already performed on an outpatient basis with little long-term recurrence.

However, laparoscopic herniorrhaphy is thought to offer the following advantages:

  • less postoperative pain, both acutely and more chronically due to a reduced incidence of neuromata
  • less chance of spermatic cord or testicular injury
  • less risk of postoperative orchitis and hence testicular atrophy
  • a shortened convalescence period
  • more rapid return of postoperative activity

There is little consensus as to the long-term benefit of laparoscopic herniorrhaphy: there are few studies.

NICE guidance states that for the repair of primary inguinal hernia, open (mesh) should be considered the preferred surgical procedure. However for the repair of recurrent and bilateral inguinal hernia, laparoscopic surgery should be considered (1).

Reference:

  • 1) NICE (April 2001). Summary of Guidance issued to the NSH in England and Wales, Laparoscopic surgery for inguinal hernia, 2, 22.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.